ACP Issues Guideline for Treating Acute, Subacute, Chronic LBP

Share this content:
ACP Issues Guideline for Treating Acute, Subacute, Chronic LBP
ACP Issues Guideline for Treating Acute, Subacute, Chronic LBP

TUESDAY, Feb. 14, 2017 (HealthDay News) -- First-line therapy for patients with low back pain should be simple non-pharmacological remedies -- from heat wraps to physical therapy, according to a new clinical practice guideline from the American College of Physicians (ACP) published online Feb. 14 in the Annals of Internal Medicine.

The recommendations are based on a review of studies of evidence for various stages of low back pain. In many cases, the ACP found, the therapies -- pharmacological or not -- showed small to moderate benefits.

In general, the ACP said, patients with low back pain should first try non-pharmacological options. For pain that has lasted fewer than 12 weeks, research suggests that heat wraps, massage, acupuncture, and spinal manipulation may ease pain and restore function to a moderate degree. If the pain lasts more than 12 weeks, studies suggest some non-pharmacological options can still be helpful, according to the guidelines. Those include exercise therapy; acupuncture; mind-body therapies like yoga, tai chi, mindfulness-based stress reduction, and guided relaxation techniques; and cognitive behavioral therapy.

When medication is used, the ACP advises starting with nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen -- or possibly muscle relaxants. Acetaminophen is no longer recommended. Citing moderate-quality evidence, the guideline recommends opioids as an option only in patients who have failed all aforementioned treatments, and only if the potential benefits outweigh the risks.

Review 1
Review 2
Clinical Practice Guideline

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »